Classifying dementia progression using microbial profiling of saliva
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- Switzerland
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Alzheimer's disease [X]Dementia in Alzheimer's disease,[X]Dementia in Alzheimer's disease (disorder),AD,AD - Alzheimer's disease,Alzheimer Dementia,Alzheimer dementia,Alzheimer Dementia, Presenile,ALZHEIMER DIS,Alzheimer Disease,Alzheimer disease,Alzheimer disease, familial,Alzheimer Type Dementia,Alzheimer's,Alzheimer's Dementia,Alzheimer's dementia,Alzheimer's disease,Alzheimer's disease (disorder),Alzheimer's disease, NOS,Alzheimers,Alzheimers Dementia,Alzheimers dementia,ALZHEIMERS DIS,Alzheimers disease,DAT - Dementia Alzheimer's type,Dementia in Alzheimer's disease,Dementia in Alzheimer's disease (disorder),Dementia in Alzheimer's disease, unspecified (disorder),Dementia of the Alzheimer's type,Dementia, Alzheimer Type,Dementia, Presenile,Dementia, Presenile Alzheimer,Disease, Alzheimer,Disease, Alzheimer's,Presenile Alzheimer Dementia,sporadic Alzheimer's disease,alzheimer's disease
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Cognitively Normal Healthy (CNh)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Cognitively Normal at risk (CNr)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Cognitively normal people with hyposmia
- Group 0 sample size Number of subjects in the control (unexposed) group
- 27
- Group 1 sample size Number of subjects in the case (exposed) group
- 15
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- ANOVA
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
Signature 1
Source: Figure 1C
Description: Significantly different bacterial taxa in CNr and CNh
Abundance in Group 1: increased abundance in Cognitively Normal at risk (CNr)
NCBI | Quality Control | Links |
---|---|---|
Leptotrichia wadei |
Revision editor(s): AaishahM
Signature 2
Source: Figure 2
Description: Significantly different bacterial taxa in CNr and CNh
Abundance in Group 1: decreased abundance in Cognitively Normal at risk (CNr)
NCBI | Quality Control | Links |
---|---|---|
Filifactor villosus |
Revision editor(s): AaishahM
Experiment 2
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Mild Cognitive Impairment (MCI)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Mild Cognitive Impairment (MCI)
- Group 1 sample size Number of subjects in the case (exposed) group
- 21
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 1C
Description: Significantly different bacterial taxa in MCI and CNh
Abundance in Group 1: increased abundance in Mild Cognitive Impairment (MCI)
NCBI | Quality Control | Links |
---|---|---|
Leptotrichia wadei |
Revision editor(s): AaishahM
Signature 2
Source: Figure 1C
Description: Significantly different bacterial taxa in MCI and CNh
Abundance in Group 1: decreased abundance in Mild Cognitive Impairment (MCI)
NCBI | Quality Control | Links |
---|---|---|
Filifactor villosus |
Revision editor(s): AaishahM
Experiment 3
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Alzheimer's Disease (AD) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Alzheimer's Disease
- Group 1 sample size Number of subjects in the case (exposed) group
- 17
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 1C
Description: Significantly different bacterial taxa in CAD patients and CNh
Abundance in Group 1: decreased abundance in Alzheimer's Disease (AD) patients
NCBI | Quality Control | Links |
---|---|---|
Filifactor villosus | ||
Leptotrichia wadei |
Revision editor(s): AaishahM
Experiment 4
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Cognitively Normal at risk (CNr)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Cognitively normal people with hyposmia
- Group 1 sample size Number of subjects in the case (exposed) group
- 15
Signature 1
Source: Figure 1D + Figure 1E
Description: Significantly different bacterial taxa in CNr and CNh
Abundance in Group 1: decreased abundance in Cognitively Normal at risk (CNr)
NCBI | Quality Control | Links |
---|---|---|
Alloprevotella tannerae | ||
Porphyromonas gingivalis | ||
Filifactor alocis | ||
Cardiobacterium valvarum |
Revision editor(s): AaishahM
Experiment 5
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Mild Cognitive Impairment (MCI)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Mild Cognitive Impairment (MCI)
- Group 1 sample size Number of subjects in the case (exposed) group
- 21
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 1D + Figure 1E
Description: Significantly different bacterial taxa in MCI and CNh
Abundance in Group 1: increased abundance in Mild Cognitive Impairment (MCI)
NCBI | Quality Control | Links |
---|---|---|
Cardiobacterium valvarum |
Revision editor(s): AaishahM
Signature 2
Source: Figure 1D + Figure 1E
Description: Significantly different bacterial taxa in MCI and CNh
Abundance in Group 1: decreased abundance in Mild Cognitive Impairment (MCI)
NCBI | Quality Control | Links |
---|---|---|
Porphyromonas gingivalis | ||
Alloprevotella tannerae | ||
Filifactor alocis |
Revision editor(s): AaishahM
Experiment 6
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Alzheimer's Disease (AD) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Alzheimer's Disease
- Group 1 sample size Number of subjects in the case (exposed) group
- 17
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 1D + Figure 1E
Description: Significantly different bacterial taxa in AD patients and CNh
Abundance in Group 1: increased abundance in Alzheimer's Disease (AD) patients
NCBI | Quality Control | Links |
---|---|---|
Cardiobacterium valvarum |
Revision editor(s): AaishahM
Signature 2
Source: Figure 1D + Figure 1E
Description: Significantly different bacterial taxa in AD patients and CNh
Abundance in Group 1: decreased abundance in Alzheimer's Disease (AD) patients
NCBI | Quality Control | Links |
---|---|---|
Porphyromonas gingivalis | ||
Alloprevotella tannerae | ||
Filifactor alocis |
Revision editor(s): AaishahM
Experiment 7
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Cognitively Normal at risk (CNr)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Cognitively normal people with hyposmia
- Group 1 sample size Number of subjects in the case (exposed) group
- 15
Lab analysis
Statistical Analysis
- Statistical test
- LEfSe
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 2.0
Signature 1
Source: Figure S2A + Figure S2B
Description: Significantly different bacterial taxa in CNr and CNh
Abundance in Group 1: increased abundance in Cognitively Normal at risk (CNr)
NCBI | Quality Control | Links |
---|---|---|
Calothrix | ||
Leptotrichia hofstadii | ||
Cyanophyceae | ||
Rothia mucilaginosa |
Revision editor(s): AaishahM
Signature 2
Source: Figure S2A + Figure S2B
Description: Significantly different bacterial taxa in CNr and CNh
Abundance in Group 1: decreased abundance in Cognitively Normal at risk (CNr)
NCBI | Quality Control | Links |
---|---|---|
Peptostreptococcaceae | ||
Filifactor | ||
Rhodothermus | ||
Rhodothermus clarus |
Revision editor(s): AaishahM
Experiment 8
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Mild Cognitive Impairment (MCI)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Mild Cognitive Impairment (MCI)
- Group 1 sample size Number of subjects in the case (exposed) group
- 21
Lab analysis
Statistical Analysis
Signature 1
Source: Figure S2C + Figure S2D
Description: Significantly different bacterial taxa in MCI and CNh
Abundance in Group 1: increased abundance in Mild Cognitive Impairment (MCI)
NCBI | Quality Control | Links |
---|---|---|
Leptotrichia | ||
Leptotrichiaceae | ||
Fusobacteriales | ||
Streptococcus mutans | ||
Streptococcus troglodytae | ||
Leptotrichia wadei | ||
Fusobacteriia |
Revision editor(s): AaishahM
Signature 2
Source: Figure S2C + Figure S2D
Description: Significantly different bacterial taxa in MCI and CNh
Abundance in Group 1: decreased abundance in Mild Cognitive Impairment (MCI)
Revision editor(s): AaishahM
Experiment 9
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Alzheimer's Disease (AD) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Alzheimer's Disease
- Group 1 sample size Number of subjects in the case (exposed) group
- 17
Lab analysis
Statistical Analysis
Signature 1
Source: Figure S2E + Figure S2F
Description: Significantly different bacterial taxa in AD patients and CNh
Abundance in Group 1: increased abundance in Alzheimer's Disease (AD) patients
NCBI | Quality Control | Links |
---|---|---|
Aminiphilus | ||
Calothrix | ||
Kocuria | ||
Cyanophyceae | ||
Aminiphilus circumscriptus | ||
Kocuria rosea | ||
Streptococcus sobrinus |
Revision editor(s): AaishahM
Signature 2
Source: Figure S2E + Figure S2F
Description: Significantly different bacterial taxa in AD patients and CNh
Abundance in Group 1: decreased abundance in Alzheimer's Disease (AD) patients
NCBI | Quality Control | Links |
---|---|---|
Spirochaetaceae | ||
Treponema | ||
Peptoniphilus methioninivorax | ||
Spirochaetia | ||
Spirochaetales | ||
Alloprevotella tannerae | ||
Filifactor villosus |
Revision editor(s): AaishahM